Virtual reality is emerging in healthcare as a high-tech solution to problems as varied as training doctors, reducing medical errors and helping patients manage pain.
Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions. That's why today's clinical lab is more important than ever. About 13 billion diagnostic tests are performed in the U.S. each year, and nearly 70 percent of critical care decisions are driven by...
The maker of a permanent contraceptive implant subject to thousands of injury reports from women and repeated safety restrictions by regulators said Friday that it will stop selling the device in the U.S.
Abbott Laboratories needs to decide whether to jump back into the merger arena or rely on internal revenue sources to drive growth and support Abbott's shares, which have leveled off since climbing 40% to a five-year peak of $63.62 during the 12 months ended in March.
The CMS is considering covering a brain stimulation therapy device that helps treat depression in patients who don't respond to other treatments. Hospitals could receive up to $30,000 per patient if the agency covers the device.
HonorHealth saved $1.5 million when it renegotiated prices for knee and hip implants. Hospitals nationwide are looking for ways to eliminate cost variation in this service line.
Sixty-two percent of health system executives support Amazon's growing presence in the medical supply sector and nearly the same amount said the company could successfully deliver supplies faster and at a lower price, according to a new survey.
Chicago-based hospital bed and medical device supplier Hill-Rom Holdings appointed John Groetelaars president and CEO, effective May 14.
In the Medical Device Safety Action Plan, FDA regulators set forth ideas for getting safer devices to patients faster.
The FDA's approval process for medical devices has been criticized for years for failing to catch problems with defective implants.
Generic-drug manufacturers, which source most of their active ingredients from China and India, could be hit the hardest by President Donald Trump's proposed tariffs, experts said.
The agency approved marketing a device that can detect diabetic retinopathy by analyzing images of the eye.